Communication About Hereditary Cancers on Social Media: A Content Analysis of Tweets About Hereditary Breast and Ovarian Cancer and Lynch Syndrome.

Main|Search|PHGKB






Last Posted: Dec 09, 2018

---

• Communication About Hereditary Cancers on Social Media: A Content Analysis of Tweets About Hereditary Breast and Ovarian Cancer and Lynch Syndrome.
  Allen Caitlin G et al. Journal of cancer education : the official journal of the American Association for Cancer Education 2018 Dec
• A multi-gene panel beyond BRCA1/BRCA2 to identify new breast cancer-predisposing mutations by a picodroplet PCR followed by a next-generation sequencing strategy: a pilot study.
  Nunziato Marcella et al. Analytica chimica acta 2019 Jan 1046154-162
• Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.
  Frey Melissa K et al. Cancer 2018 Nov
• Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk.
  Terry Mary Beth et al. Journal of the National Cancer Institute 2018 Nov
• Uterine cancer in Jewish Israeli BRCA1/BRCA2 mutation carriers.
  Laitman Yael et al. Cancer 2018 Nov
• The rate of the recurrent MSH6 mutations in Ashkenazi Jewish breast cancer patients.
  Bernstein-Molho Rinat et al. Cancer causes & control : CCC 2018 Nov
• Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer-an European consensus statement and expert recommendations.
  Singer Christian F et al. European journal of cancer (Oxford, England : 1990) 2018 Nov 10654-60
• No. 366-Gynaecologic Management of Hereditary Breast and Ovarian Cancer.
  Jacobson Michelle et al. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2018 Nov 40(11) 1497-1510
• Non-Coding Variants in BRCA1 and BRCA2 Genes: Potential Impact on Breast and Ovarian Cancer Predisposition.
  Santana Dos Santos Elizabeth et al. Cancers 2018 Nov 10(11)
• The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: high frequency of FANCM pathogenic variants.
  Schubert Stephanie et al. International journal of cancer 2018 Nov

more